Dr. Vutikullird is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5630 Cerritos Ave
Cypress, CA 90630Phone+1 714-252-0700
Education & Training
Long Beach Memorial Medical CenterResidency, Family Medicine, 2003 - 2006
College of Osteopathic Medicine of the PacificClass of 2003
Certifications & Licensure
CA State License 2005 - 2025- American Board of Family Medicine Family Medicine
Clinical Trials
- Safety Study of Single Administration Post-exposure Prophylaxis Treatment for Marburg Virus Start of enrollment: 2011 May 01
- A Phase I Study in Healthy Volunteers to Assess the Effect of Cytochrome3A4 (CYP3A4) Inhibitors (Diltiazem and Itraconazole) on the Pharmacokinetics (PK) of AZD3293 and the Effects of AZD3293 on the Pharmacokinetics of Midazolam, a Cytochrome 3A4 and Cytochrome 3A5 (CYP3A4/CYP3A5) Substrate Start of enrollment: 2013 Dec 01
Publications & Presentations
PubMed
- Correction to: A Multi‑Center, Open‑Label, Pharmacokinetic Drug Interaction Study of Erenumab and a Combined Oral Contraceptive in Healthy Females.Yang Xu, Kristin Gabriel, Yi Wang, Yanchen Zhou, Osaro Eisele
CNS Drugs. 2019-05-01 - 3 citationsA Multi-Center, Open-Label, Pharmacokinetic Drug Interaction Study of Erenumab and a Combined Oral Contraceptive in Healthy Females.Yang Xu, Kristin Gabriel, Yi Wang, Yanchen Zhou, Osaro Eisele
CNS Drugs. 2019-05-01 - 23 citationsEffect of itraconazole, food, and ethnic origin on the pharmacokinetics of ivosidenib in healthy subjects.David Dai, Hua Yang, Salah Nabhan, Hua Liu, Denice Hickman
European Journal of Clinical Pharmacology. 2019-04-23
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
